Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06098144 · ClinicalTrials.gov registry record · Phase 4
Smoking Cessation Program in the Construction Sector
A Phase 4 study of Smoking Cessation and Tobacco Smoking, sponsored by University of Miami.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 608
- Enrollment target
- 1
- Study location
NCT06098144: Recruiting Phase 4 study of Smoking Cessation and Tobacco Smoking, sponsored by University of Miami.
NCT06098144 is a Phase 4 study of Smoking Cessation and Tobacco Smoking that is actively recruiting participants, run by University of Miami. The registered enrollment target is 608 participants, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (29% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06098144, a Phase 4 study of Smoking Cessation and Tobacco Smoking, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 608 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of this study is to identify the optimal adaptive smoking cessation program for the construction sector in terms of effectiveness, cost-effectiveness, and potential implementation.
Primary Outcome
Will be collected as the difference in percentage of participants who quit smoking at the 12-month follow-up assessment between the three treatment groups.
Conditions Studied
Interventions
- DRUG Nicorette
- BEHAVIORAL Tobacco Quit-line
- BEHAVIORAL Brief Behavioral Counseling
- BEHAVIORAL Intensive Behavioral Counseling
Study Locations (1)
Florida
- Don Soffer Clinical Research Center - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 608 participants |
| Start Date | 2024-04-10 |
| Est. Completion | 2027-02-28 |
| Phase | Phase 4 |
What NCT06098144 shows while recruiting
NCT06098144 is an interventional study that assigns participants to a tested intervention. The registered 608 participants enrollment target is mid-sized for trials with a published cap, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (29% higher).
The record links to 3 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which Nicorette is the first listed.
NCT06098144 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06098144 about?
NCT06098144 is a clinical study titled "Smoking Cessation Program in the Construction Sector". The main objective of this study is to identify the optimal adaptive smoking cessation program for the construction sector in terms of effectiveness, cost-effectiveness, and potential implementation.
What is the current status of trial NCT06098144?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 608 participants. The study started on 2024-04-10. Estimated completion is 2027-02-28.
What conditions does trial NCT06098144 study?
This clinical trial studies the following conditions: Smoking Cessation, Tobacco Smoking, Tobacco Use Cessation.
What interventions are being tested in trial NCT06098144?
The interventions under investigation include: Nicorette (DRUG), Tobacco Quit-line (BEHAVIORAL), Brief Behavioral Counseling (BEHAVIORAL), Intensive Behavioral Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT06098144?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06098144 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06098144's enrollment target sits among peer trials
608 46th of 188 higher than 143 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
The Options 2 Study
RECRUITING · Phase 4
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
-
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
RECRUITING · Phase 4
-
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
ACTIVE NOT RECRUITING · Phase 4
-
Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02064673 · 608 participants · Phase 3
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
- NCT06091202 · 608 participants · Phase 3
Tele-Collaborative Outreach to Rural Patients With Chronic Pain
- NCT00823654 · 609 participants
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
- NCT03536312 · 610 participants · NA
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI